Directory
>
Daniel Nomura
Daniel Nomura
Co-Founder | Frontier Medicines
Berkeley, California, United States
Daniel Nomura
Summary
Daniel Nomura is a distinguished Professor of Chemical Biology and Molecular Therapeutics at the University of California, Berkeley, with a focus on innovative therapeutic strategies for addressing complex diseases. He co-directs the Molecular Therapeutics Initiative and leads the Novartis-Berkeley Translational Chemical Biology Institute, where he explores the use of chemoproteomics in drug discovery. As a co-founder of Frontier Medicines and Vicinitas Therapeutics, he is at the forefront of developing next-generation therapies targeting the undruggable proteome. His academic journey includes a Ph.D. in Molecular Toxicology from UC Berkeley and a postdoctoral fellowship at Scripps Research. Daniel's work has garnered numerous accolades, including the National Cancer Institute Outstanding Investigator Award and the Searle Scholar Award. Beyond academia, he serves on several scientific advisory boards and is an investment advisory partner, bridging the gap between research and practical application in the biotech sector. His extensive publication record reflects his commitment to advancing the field of chemical biology.
Daniel Nomura
Work Experience
Co-Founder at
Peter Bankowski, Uwe Harste, Thomas Marquardt und Peter Levin
August 2024 - Present
Co-Director of the Molecular Therapeutics Initiative at
Molecular Therapeutics Initiative
January 2024 - Present
iPartner at
The Column Group
August 2023 - Present
Advisory Partner at
Andreessen Horowitz
March 2023 - Present
Investment Advisory Board Member at
Droia Ventures
November 2022 - Present
Professor of Chemical Biology and Molecular Therapeutics at
The University California Berkeley
July 2022 - Present
Founder, Scientific Adviser, and Board Member at
Vicinitas Therapeutics, Inc.
May 2022 - Present
Director at
Novartis Berkeley Translational Chemical Biology Institute
July 2017 - Present
Co-Founder and Scientific Adviser at
Frontier Medicines
June 2017 - Present
Adjunct Professor at
University of California, San Francisco
March 2016 - Present
Professor at
The University California Berkeley
July 2019 - June 2022
Associate Professor at
The University California Berkeley
July 2015 - July 2019
Assistant Professor at
The University California Berkeley
July 2011 - July 2015
Postdoctoral Fellow at
The Scripps Research Institute
July 2008 - July 2011
Graduate Student Researcher at
The University California Berkeley
August 2004 - June 2008
Undergraduate Reseacher at
The University California Berkeley
June 2000 - July 2004
Daniel Nomura
Education
University of California, Berkeley, Doctor Of Philosophy - Phd
January 2004 - January 2008
University of California, Berkeley, Bachelor Of Arts - Ba
January 1999 - January 2003
Frequently Asked Questions about Daniel Nomura
What is Daniel Nomura email address?
Daniel Nomura's primary email address is ******@thecolumngroup.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Daniel Nomura work for?
Daniel Nomura is a Co-Founder at Frontier Medicines, a company specializing in Commercial physical research.
Where Daniel Nomura graduated from?
Daniel Nomura holds a degree in Molecular Toxicology from University of California, Berkeley.
How can I directly contact Daniel Nomura?
To contact Daniel Nomura directly, you can use the email address ******@thecolumngroup.com. Complete contact information is available upon registration with Muraena.
Who is Daniel Nomura?
Daniel Nomura is a distinguished Professor of Chemical Biology and Molecular Therapeutics at the University of California, Berkeley, with a focus on innovative therapeutic strategies for addressing complex diseases. He co-directs the Molecular Therapeutics Initiative and leads the Novartis-Berkeley Translational Chemical Biology Institute, where he explores the use of chemoproteomics in drug discovery. As a co-founder of Frontier Medicines and Vicinitas Therapeutics, he is at the forefront of developing next-generation therapies targeting the undruggable proteome. His academic journey includes a Ph.D. in Molecular Toxicology from UC Berkeley and a postdoctoral fellowship at Scripps Research. Daniel's work has garnered numerous accolades, including the National Cancer Institute Outstanding Investigator Award and the Searle Scholar Award. Beyond academia, he serves on several scientific advisory boards and is an investment advisory partner, bridging the gap between research and practical application in the biotech sector. His extensive publication record reflects his commitment to advancing the field of chemical biology.
Daniel`s contact details
******@thecolumngroup.com
*******@berkeley.edu
Colleagues
VP, Information Technology
Vice President, Head of Chemistry
Chief Of Staff
Co-director, Molecular Therapeutics Initiative
Vice President of DMPK
Chief Innovation Officer
Vice President Finance
Chief Science Officer
Chief Technology Officer
Senior Vice President, Strategy and Corporate Affairs